Featured Content

Update on Pharmacotherapeutic Options for Rheumatoid Arthritis 10/18/2013

The chronic systemic inflammatory response associated with rheumatoid arthritis affects most joints and their surrounding tissues.

Related Content

Antimicrobial Therapy for Community-Acquired Pneumonia

Antibiotic resistance and the risk of fatal adverse events make it challenging to select an agent.

Cutaneous Fungal Infections

Cutaneous fungal infections are superficial infections typically involving the skin, hair, and nails.

Advice for Patients With Tremor

Self-help techniques may provide some relief from symptoms such as shaking.



Management of Dual Diagnosis of Parkinson’s Disease and a Mental Health Disorder

Mental health disorders are frequently seen in patients with Parkinson’s disease, possibly as a result of the complex imbalance of neurotransmitters in both disease states.

Examining Nonprescription Options for Heartburn

Various antacids and acid reducers are available to treat this common GI ailment.



FDA Approves First New Lupus Therapy in Over 50 Years 4/20/2011



An Overview of Systemic Lupus Erythematosus 9/20/2010

Additional research and new treatments for lupus are critically needed.


Dermatologic Signs of Rheumatoid Arthritis 4/20/2009

Rheumatoid arthritis, the most common inflammatory arthritis, is a chronic autoimmune disease and an important cause of disability in seniors.

Drug–Drug Interactions with HIV Antiretroviral Therapy 4/18/2008

Drug-drug interactions are often a serious complication of taking multiple medications and account for 3% to 5% of all in-hospital medication errors.

The Antiphospholipid Syndrome 1/23/2008

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence of antiphospholipid antibodies, manifesting with vascular thrombosis and/or recurrent fetal loss.

Sjögren’s Syndrome 3/21/2007

Sjögren's (SHOW-grins) syndrome is an autoimmune disease that attacks the exocrine glands (i.

Advertisement